629.86
Schlusskurs vom Vortag:
$628.39
Offen:
$634.47
24-Stunden-Volumen:
13.22M
Relative Volume:
0.83
Marktkapitalisierung:
$1.59T
Einnahmen:
$200.97B
Nettoeinkommen (Verlust:
$60.46B
KGV:
26.81
EPS:
23.4909
Netto-Cashflow:
$46.11B
1W Leistung:
+9.64%
1M Leistung:
-3.70%
6M Leistung:
-10.70%
1J Leistung:
+15.30%
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
META
Meta Platforms Inc
|
629.86 | 1.59T | 200.97B | 60.46B | 46.11B | 23.49 |
|
GOOGL
Alphabet Inc
|
317.24 | 3.85T | 403.06B | 132.17B | 73.27B | 10.81 |
|
GOOG
Alphabet Inc
|
315.72 | 3.83T | 403.06B | 132.17B | 73.27B | 10.81 |
|
SPOT
Spotify Technology S A
|
475.99 | 100.19B | 19.43B | 2.56B | 3.41B | 9.6489 |
|
DASH
Doordash Inc
|
152.58 | 67.14B | 13.72B | 932.00M | 1.83B | 2.1265 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Bull vs. Bear: Is Nvidia a Buy or Sell? Let's Look at the Bullish and Bearish Cases for the Stock. - The Motley Fool
Meta Stock Needs to Show How Much Cash It Can Squeeze Out of Its New AI Tools before Q1; Barclays Reiterates Buy Forecast - Yahoo Finance
Amazon, Meta, Levi Strauss And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week - Benzinga
Mass. high court allows AG’s lawsuit against Meta to move forward - Boston.com
Thurston Springer Miller Herd & Titak Inc. Raises Position in Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. $META is Stratos Wealth Advisors LLC's 8th Largest Position - MarketBeat
Meta Platforms, Inc. $META Holdings Lessened by Cypress Funds LLC - MarketBeat
Down 23%! Should I buy Meta Platforms for my ISA or SIPP? - Yahoo Finance UK
American National Bank & Trust Buys 1,184 Shares of Meta Platforms, Inc. $META - MarketBeat
Analysts Are Bullish on These Communication Services Stocks: Tencent Holdings (TCEHY), Meta Platforms (META) - The Globe and Mail
Meta Platforms Inc Shs Thailand Depositary Receipts Repr 1 Sh Trade Ideas — SET:META23 - TradingView
This Viral Bagel Chain Could Be Worth $300 Million After Tiger Global's BetMeta Platforms (NASDAQ:META - Benzinga
Former OpenAI Stargate Leaders Plan to Join Meta Platforms - Bloomberg.com
Massive News for Meta Stock Investors - The Globe and Mail
CoreWeave Inks $21B AI Infrastructure Deal With Meta Platforms - qz.com
Meta Platforms: A Strong Contender in the Social Media Arena - The Globe and Mail
Meta seeks to build three-story atrium at aging Menlo Park headquarters - The Business Journals
Personal Superintelligence: How Safe is Meta's Muse Spark? - Cyber Magazine
Meta must face Instagram public nuisance case, Massachusetts high court says - Courthouse News
Meta Stops Client Recruitment Ads for Social Media Addiction Lawsuits - The Legal Examiner
Meta Must Face Massachusetts AG's Addiction Suit 04/13/2026 - MediaPost
NY AG warns of Meta deepfake investment scams. What to know - Democrat and Chronicle
In first ruling of its kind, Mass. high court says Meta not shielded from lawsuits over addictive features - CommonWealth Beacon
Top Mass. court allows lawsuit against Meta to move forward - WCVB
Meta Platforms Gave 21 Billion Reasons for CoreWeave Shareholders to Be Bullish - The Motley Fool
Meta's AI Outlook Brightens With Muse Spark Release - Benzinga
CoreWeave announces $21B expanded AI infrastructure agreement with Meta - ROI-NJ
Meta pulls Facebook ads recruiting for social media addiction lawsuits - Yahoo Finance
Meta is banning ads plaintiff lawyers as it faces social media addiction lawsuits - qz.com
Meta must face Massachusetts lawsuit over youth social media addiction, court rules - The Guardian
Meta Bans Lawsuit Ads After $380M Verdicts - Impakter
Why Meta’s $1B Executive Pay Plan Isn’t What Investors Think - MarketWise
Meta must face youth addiction lawsuit by Massachusetts, court rules - CNBC
Is Meta Platforms (META) The Most Undervalued AI Stock To Buy Now? - Yahoo Finance
Meta to pay CoreWeave $21bn for additional cloud capacity - Silicon Republic
Meta Platforms (NASDAQ:META) Given New $800.00 Price Target at Wolfe Research - MarketBeat
CFRA Just Upgraded Meta to Strong Buy. The AI Turnaround Story Is Getting Hard to Argue With - Yahoo Finance
Analysts Offer Insights on Communication Services Companies: Meta Platforms (META) and AppLovin (APP) - The Globe and Mail
Meta Has Found Its AI Footing (NASDAQ:META) - Seeking Alpha
Rosenblatt Securities Remains a Buy on Meta Platforms (META) - The Globe and Mail
Meta Platforms (META) Sees 87% Surge in AI App Downloads Followi - GuruFocus
Meta moves fast toward a world where AI builds the software - Computerworld
Meta Price Prediction: Bull and Bear Case - Yahoo Finance
Analysts’ Opinions Are Mixed on These Communication Services Stocks: Meta Platforms (META) and fuboTV (FUBO) - The Globe and Mail
Meta Platforms (META) Gets a Buy from Citi - The Globe and Mail
Wolfe Research Adjusts Price Target on Meta Platforms to $800 From $850, Maintains Outperform Rating - marketscreener.com
Meta AI app downloads on App Store surge after Muse Spark AI model: ST - Seeking Alpha
Rubicon Global Capital Ltd Reduces Meta Platforms Stake - National Today
Zacks Investment Ideas feature highlights: Meta Platforms, Nvidia, Broadcom, Intel, Comfort Systems USA, TAN and Bloom Energy - Zacks Investment Research
Meta Banks on AI to Clear the Smoke of Social-Media Lawsuits - WSJ
Meta Platforms, Inc. $META is Quintet Private Bank Europe S.A.'s 10th Largest Position - MarketBeat
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
Meta Platforms Inc-Aktie (META) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Mar 23 '26 |
Sale |
605.38 |
629 |
380,784 |
2,657 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):